T cell egress via lymphatic vessels is tuned by antigen encounter and limits tumor control.
Journal
Nature immunology
ISSN: 1529-2916
Titre abrégé: Nat Immunol
Pays: United States
ID NLM: 100941354
Informations de publication
Date de publication:
04 2023
04 2023
Historique:
received:
11
05
2022
accepted:
25
01
2023
medline:
3
4
2023
pubmed:
1
3
2023
entrez:
28
2
2023
Statut:
ppublish
Résumé
Antigen-specific CD8
Identifiants
pubmed: 36849745
doi: 10.1038/s41590-023-01443-y
pii: 10.1038/s41590-023-01443-y
doi:
Substances chimiques
Receptors, CXCR4
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
664-675Subventions
Organisme : NCI NIH HHS
ID : P50 CA225450
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA238163
Pays : United States
Organisme : NIAMS NIH HHS
ID : R56 AR078686
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA263001
Pays : United States
Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Nature America, Inc.
Références
Steele, M. M. & Lund, A. W. Afferent lymphatic transport and peripheral tissue. J. Immunol. 206, 264–272 (2021).
doi: 10.4049/jimmunol.2001060
pubmed: 33397740
Lund, A. W. et al. Lymphatic vessels regulate immune microenvironments in human and mouse melanoma. J. Clin. Invest. 126, 3389–3402 (2016).
doi: 10.1172/JCI79434
pubmed: 27525437
pmcid: 5004967
Loo, C. P. et al. Lymphatic vessels balance viral dissemination and immune activation following cutaneous viral infection. Cell Rep. 20, 3176–3187 (2017).
doi: 10.1016/j.celrep.2017.09.006
pubmed: 28954233
pmcid: 5621787
Alitalo, A. K. et al. VEGF-C and VEGF-D blockade inhibits inflammatory skin carcinogenesis. Cancer Res. 73, 4212–4221 (2013).
doi: 10.1158/0008-5472.CAN-12-4539
pubmed: 23695550
Lund, A. W. et al. VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics. Cell Rep. 1, 191–199 (2012).
doi: 10.1016/j.celrep.2012.01.005
pubmed: 22832193
Gkountidi, A. O. et al. MHC class II antigen presentation by lymphatic endothelial cells in tumors promotes intratumoral regulatory T cell-suppressive functions. Cancer Immunol. Res. 9, 748–764 (2021).
doi: 10.1158/2326-6066.CIR-20-0784
pubmed: 33952631
Garnier, L. et al. IFN-γ-dependent tumor-antigen cross-presentation by lymphatic endothelial cells promotes their killing by T cells and inhibits metastasis. Sci. Adv. 8, eabl5162 (2022).
doi: 10.1126/sciadv.abl5162
pubmed: 35675399
pmcid: 9176743
Lane, R. S. et al. IFNγ-activated dermal lymphatic vessels inhibit cytotoxic T cells in melanoma and inflamed skin. J. Exp. Med. 215, 3057–3074 (2018).
doi: 10.1084/jem.20180654
pubmed: 30381467
pmcid: 6279400
Joyce, J. A. & Fearon, D. T. T cell exclusion, immune privilege, and the tumor microenvironment. Science 348, 74–80 (2015).
doi: 10.1126/science.aaa6204
pubmed: 25838376
Simoni, Y. et al. Bystander CD8
doi: 10.1038/s41586-018-0130-2
pubmed: 29769722
Khan, T. N., Mooster, J. L., Kilgore, A. M., Osborn, J. F. & Nolz, J. C. Local antigen in nonlymphoid tissue promotes resident memory CD8
doi: 10.1084/jem.20151855
pubmed: 27217536
pmcid: 4886364
Mackay, C. R., Kimpton, W. G., Brandon, M. R. & Cahill, R. N. Lymphocyte subsets show marked differences in their distribution between blood and the afferent and efferent lymph of peripheral lymph nodes. J. Exp. Med. 167, 1755–1765 (1988).
doi: 10.1084/jem.167.6.1755
pubmed: 3290379
Olszewski, W. L., Grzelak, I., Ziolkowska, A. & Engeset, A. Immune cell traffic from blood through the normal human skin to lymphatics. Clin. Dermatol. 13, 473–483 (1995).
doi: 10.1016/0738-081X(95)00087-V
pubmed: 8665458
Tomura, M. et al. Monitoring cellular movement in vivo with photoconvertible fluorescence protein ‘Kaede’ transgenic mice. Proc. Natl Acad. Sci. USA 105, 10871–10876 (2008).
doi: 10.1073/pnas.0802278105
pubmed: 18663225
pmcid: 2504797
Steele, M. et al. Quantifying leukocyte egress from mouse skin and tumors. J. Vis. Exp. 143, 58704 (2019).
Torcellan, T. et al. In vivo photolabeling of tumor-infiltrating cells reveals highly regulated egress of T-cell subsets from tumors. Proc. Natl Acad. Sci. 114, 5677–5682 (2017).
doi: 10.1073/pnas.1618446114
pubmed: 28507145
pmcid: 5465915
Li, Z. et al. In vivo labeling reveals continuous trafficking of TCF-1
doi: 10.1084/jem.20210749
pubmed: 35472220
pmcid: 9048291
Brown, M. N. et al. Chemoattractant receptors and lymphocyte egress from extralymphoid tissue: changing requirements during the course of inflammation. J. Immunol. 185, 4873–4882 (2010).
doi: 10.4049/jimmunol.1000676
pubmed: 20833836
Mäkinen, T. et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat. Med. 7, 199–205 (2001).
doi: 10.1038/84651
pubmed: 11175851
Bengsch, B. et al. Epigenomic-guided mass cytometry profiling reveals disease-specific features of exhausted CD8 T cells. Immunity 48, 1029–1045 (2018).
doi: 10.1016/j.immuni.2018.04.026
pubmed: 29768164
pmcid: 6010198
Utzschneider, D. T. et al. T cell factor 1-expressing memory-like CD8
doi: 10.1016/j.immuni.2016.07.021
pubmed: 27533016
Siddiqui, I. et al. Intratumoral Tcf1
doi: 10.1016/j.immuni.2018.12.021
pubmed: 30635237
Schneider, O. D., Weiss, A. A. & Miller, W. E. Pertussis toxin signals through the TCR to initiate cross-desensitization of the chemokine receptor CXCR4. J. Immunol. 182, 5730–5739 (2009).
doi: 10.4049/jimmunol.0803114
pubmed: 19380820
Brinkmann, V. et al. Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat. Rev. Drug Discov. 9, 883–897 (2010).
doi: 10.1038/nrd3248
pubmed: 21031003
Skon, C. N. et al. Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8
doi: 10.1038/ni.2745
pubmed: 24162775
pmcid: 3844557
Kabashima, K. et al. CXCL12–CXCR4 engagement is required for migration of cutaneous dendritic cells. Am. J. Pathol. 171, 1249–1257 (2007).
doi: 10.2353/ajpath.2007.070225
pubmed: 17823289
pmcid: 1988874
Schmidt, T. H., Bannard, O., Gray, E. E. & Cyster, J. G. CXCR4 promotes B cell egress from Peyer’s patches. J. Exp. Med. 210, 1099–1107 (2013).
doi: 10.1084/jem.20122574
pubmed: 23669394
pmcid: 3674699
Feig, C. et al. Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer. Proc. Natl Acad. Sci. USA 110, 20212–20217 (2013).
doi: 10.1073/pnas.1320318110
pubmed: 24277834
pmcid: 3864274
Di Pilato, M. et al. CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment. Cell 184, 4512–4530 (2021).
doi: 10.1016/j.cell.2021.07.015
pubmed: 34343496
pmcid: 8719451
Wein, A. N. et al. CXCR6 regulates localization of tissue-resident memory CD8 T cells to the airways. J. Exp. Med. 216, 2748–2762 (2019).
doi: 10.1084/jem.20181308
pubmed: 31558615
pmcid: 6888981
Mackay, L. K. et al. The developmental pathway for CD103
doi: 10.1038/ni.2744
pubmed: 24162776
Schietinger, A. et al. Tumor-specific T cell dysfunction is a dynamic antigen-driven differentiation program initiated early during tumorigenesis. Immunity 45, 389–401 (2016).
doi: 10.1016/j.immuni.2016.07.011
pubmed: 27521269
pmcid: 5119632
Berkley, A. M. & Fink, P. J. Cutting edge: CD8
doi: 10.4049/jimmunol.1401870
pubmed: 25172492
Sade-Feldman, M. et al. Defining T cell states associated with response to checkpoint immunotherapy in melanoma. Cell 175, 998–1013 (2018).
doi: 10.1016/j.cell.2018.10.038
pubmed: 30388456
pmcid: 6641984
Jaiswal, A. et al. An activation to memory differentiation trajectory of tumor-infiltrating lymphocytes informs metastatic melanoma outcomes. Cancer Cell 40, 524–544 (2022).
doi: 10.1016/j.ccell.2022.04.005
pubmed: 35537413
Dankort, D. et al. BrafV600E cooperates with Pten loss to induce metastatic melanoma. Nat. Genet. 41, 544–552 (2009).
doi: 10.1038/ng.356
pubmed: 19282848
pmcid: 2705918
Gómez, D., Diehl, M. C., Crosby, E. J., Weinkopff, T. & Debes, G. F. Effector T cell egress via afferent lymph modulates local tissue. J. Immunol. 195, 3531–3536 (2015).
doi: 10.4049/jimmunol.1500626
pubmed: 26355150
Lund, A. W. Immune potential untapped: leveraging the lymphatic system for cancer immunotherapy. Cancer Immunol. Res. 10, 1042–1046 (2022).
doi: 10.1158/2326-6066.CIR-22-0266
pubmed: 35895021
pmcid: 9673990
Fankhauser, M. et al. Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanoma. Sci. Transl. Med. 9, eaal4712 (2017).
doi: 10.1126/scitranslmed.aal4712
pubmed: 28904226
Song, E. et al. VEGF-C-driven lymphatic drainage enables immunosurveillance of brain tumours. Nature 577, 689–694 (2020).
doi: 10.1038/s41586-019-1912-x
pubmed: 31942068
pmcid: 7100608
Sasso, M. S. et al. Lymphangiogenesis-inducing vaccines elicit potent and long-lasting T cell immunity against melanomas. Sci. Adv. 7, eabe4362 (2021).
doi: 10.1126/sciadv.abe4362
pubmed: 33762337
pmcid: 7990326
Hirosue, S. et al. Steady-state antigen scavenging, cross-presentation, and CD8
doi: 10.4049/jimmunol.1302492
pubmed: 24795456
pmcid: 4025611
Ceradini, D. J. et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med. 10, 858–864 (2004).
doi: 10.1038/nm1075
pubmed: 15235597
Vigl, B. et al. Tissue inflammation modulates gene expression of lymphatic endothelial cells and dendritic cell migration in a stimulus-dependent manner. Blood 118, 205–215 (2011).
doi: 10.1182/blood-2010-12-326447
pubmed: 21596851
Geherin, S. A., Wilson, R. P., Jennrich, S. & Debes, G. F. CXCR4 is dispensable for T cell egress from chronically inflamed skin via the afferent lymph. PLoS ONE 9, e95626 (2014).
doi: 10.1371/journal.pone.0095626
pubmed: 24752354
pmcid: 3994085
Burger, M. L. et al. Antigen dominance hierarchies shape TCF1
doi: 10.1016/j.cell.2021.08.020
pubmed: 34534464
pmcid: 8522630
Westcott, P. M. K. et al. Low neoantigen expression and poor T-cell priming underlie early immune escape in colorectal cancer. Nat. Cancer 2, 1071–1085 (2021).
doi: 10.1038/s43018-021-00247-z
pubmed: 34738089
pmcid: 8562866
Shakiba, M. et al. TCR signal strength defines distinct mechanisms of T cell dysfunction and cancer evasion. J. Exp. Med. 219, e20201966 (2022).
doi: 10.1084/jem.20201966
pubmed: 34935874
Lesch, S. et al. T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours. Nat. Biomed. Eng. 5, 1246–1260 (2021).
doi: 10.1038/s41551-021-00737-6
pubmed: 34083764
pmcid: 7611996
Connolly, K. A. et al. A reservoir of stem-like CD8
doi: 10.1126/sciimmunol.abg7836
pubmed: 34597124
pmcid: 8593910
Scheper, W. et al. Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers. Nat. Med. 25, 89–94 (2019).
doi: 10.1038/s41591-018-0266-5
pubmed: 30510250
Buechler, M. B. et al. Cross-tissue organization of the fibroblast lineage. Nature 593, 575–579 (2021).
doi: 10.1038/s41586-021-03549-5
pubmed: 33981032
Chen, I. X. et al. Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer. Proc. Natl Acad. Sci. USA 116, 4558–4566 (2019).
doi: 10.1073/pnas.1815515116
pubmed: 30700545
pmcid: 6410779
Chen, Y. et al. CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice. Hepatology 61, 1591–1602 (2015).
doi: 10.1002/hep.27665
pubmed: 25529917
Rosato, P. C. et al. Virus-specific memory T cells populate tumors and can be repurposed for tumor immunotherapy. Nat. Commun. 10, 567 (2019).
doi: 10.1038/s41467-019-08534-1
pubmed: 30718505
pmcid: 6362136
Weber, E. W. et al. Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling. Science 372, eaba1786 (2021).
doi: 10.1126/science.aba1786
pubmed: 33795428
pmcid: 8049103
Ding, L. & Morrison, S. J. Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches. Nature 495, 231–235 (2013).
doi: 10.1038/nature11885
pubmed: 23434755
pmcid: 3600153
Bazigou, E. et al. Genes regulating lymphangiogenesis control venous valve formation and maintenance in mice. J. Clin. Invest. 121, 2984–2992 (2011).
doi: 10.1172/JCI58050
pubmed: 21765212
pmcid: 3223924
Meeth, K., Wang, J. X., Micevic, G., Damsky, W. & Bosenberg, M. W. The YUMM lines: a series of congenic mouse melanoma cell lines with defined genetic alterations. Pigment Cell Melanoma Res. 29, 590–597 (2016).
doi: 10.1111/pcmr.12498
pubmed: 27287723
pmcid: 5331933
Wang, J. et al. UV-induced somatic mutations elicit a functional T cell response in the YUMMER1.7 mouse melanoma model. Pigment Cell Melanoma Res. 30, 428–435 (2017).
doi: 10.1111/pcmr.12591
pubmed: 28379630
pmcid: 5820096
Broggi, M. A. S., Schmaler, M., Lagarde, N. & Rossi, S. W. Isolation of mouse lymph node stromal cells. J. Vis. Exp. 19, e51803 (2014).
Medler, T. R. et al. Complement C5a fosters squamous carcinogenesis and limits T cell response to chemotherapy. Cancer Cell 34, 561–578 (2018).
doi: 10.1016/j.ccell.2018.09.003
pubmed: 30300579
pmcid: 6246036
Bolotin, D. A. et al. MiXCR: software for comprehensive adaptive immunity profiling. Nat. Methods 12, 380–381 (2015).
doi: 10.1038/nmeth.3364
pubmed: 25924071
Nazarov, V. I. et al. tcR: an R package for T cell receptor repertoire advanced data analysis. BMC Bioinformatics 16, 175 (2015).
doi: 10.1186/s12859-015-0613-1
pubmed: 26017500
pmcid: 4445501
Churchill, M. J. et al. Infection-induced lymphatic zippering restricts fluid transport and viral dissemination from skin. J. Exp. Med. 219, e20211830 (2022).
doi: 10.1084/jem.20211830
pubmed: 35353138
pmcid: 8972184
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
doi: 10.1186/s13059-014-0550-8
pubmed: 25516281
pmcid: 4302049
Krishnan, A. et al. Genome-wide prediction and functional characterization of the genetic basis of autism spectrum disorder. Nat. Neurosci. 19, 1454–1462 (2016).
doi: 10.1038/nn.4353
pubmed: 27479844
pmcid: 5803797
Tsujikawa, T. et al. Quantitative multiplex immunohistochemistry reveals myeloid-inflamed tumor-immune complexity associated with poor prognosis. Cell Rep. 19, 203–217 (2017).
doi: 10.1016/j.celrep.2017.03.037
pubmed: 28380359
pmcid: 5564306
Cao, J. et al. The single-cell transcriptional landscape of mammalian organogenesis. Nature 566, 496–502 (2019).
doi: 10.1038/s41586-019-0969-x
pubmed: 30787437
pmcid: 6434952
Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411–420 (2018).
doi: 10.1038/nbt.4096
pubmed: 29608179
pmcid: 6700744